Magnesium Bisglycinate
Natural health product licensed in Canada
- Other names
- Solaire Naturals Elemental Magnesium, Solaire Naturals Genuine Magnesium Bisglycinate 200mg, Solaire Naturals Magnesium Bisglycinate, Solaire Naturals Magnesium Bisglycinate 200mg, Solaire Naturals Magnesium Bisglycinate Clear, Solaire Naturals Magnesium Bisglycinate Lite, Solaire Naturals Magnesium Bisglycinate Moderate, Solaire Naturals Magnesium Bisglycinate complete, Solaire Naturals Magnesium Bisglycinate soft, Solaire Naturals Magnesium Bisglycinate unfiltered, Solaire Naturals Magnesium Glycinate, Symons Super Mix Elemental Magnesium, Symons Super Mix Genuine Magnesium Bisglycinate 200mg, Symons Super Mix Magnesium Bisglycinate 200mg, Symons Super Mix Magnesium Bisglycinate Clear, Symons Super Mix Magnesium Bisglycinate Lite, Symons Super Mix Magnesium Bisglycinate Moderate, Symons Super Mix Magnesium Bisglycinate complete, Symons Super Mix Magnesium Bisglycinate soft, Symons Super Mix Magnesium Bisglycinate unfiltered, Symons Super Mix Magnesium Glycinate
- Licence holder
- G. Batte Enterprises Inc.
- NPN or DIN-HM
- 80119630
- Status
- Active licence
- Licence date
- 28 June 2022
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Magnésium: up to 400 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 400 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Oxyde de magnésium | 200 mg | 400,000 µg |
| Magnésium Source : Glycinate de magnésium | 200 mg | 400,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in energy metabolism, tissue formation and bone development. Helps in the development and maintenance of bones and teeth. Helps maintain proper muscle function and tissue formation. Helps to maintain heart muscle function. Helps to maintain normal electrolyte balance. Helps to maintain the body's ability to metabolize nutrients. Provides/Source of/An electrolyte (for the maintenance of good health).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80119630
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.